Citius Pharmaceuticals Inc (CTXR) stock is higher by 41.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 88 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 98. CTXR's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, CTXR stock has a mean target price of 5.5. This means analysts expect the stock to climb 290.07% over the next 12 months. The short-term technical score for CTXR is 80.
What's Happening with CTXR Stock Today
Citius Pharmaceuticals Inc (CTXR) stock is down -2.77% while the S&P 500 is higher by 0.13% as of 10:31 AM on Tuesday, Jun 30. CTXR is lower by -$0.04 from the previous closing price of $1.45 on volume of 1,522,735 shares. Over the past year the S&P 500 has risen 3.13% while CTXR is higher by 41.00%. CTXR lost -$0.64 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Citius Pharmaceuticals Inc (CTXR) Stock.